Does TRICARE Cover Cialis (Tadalafil)?

TRICARE Formulary Placement for Tadalafil

Generic tadalafil holds a Tier 2 position on the TRICARE Uniform Formulary, meaning it is classified as a preferred generic with lower cost-sharing at military treatment facilities and TRICARE Pharmacy Home Delivery. Brand-name Cialis occupies Tier 3 as a non-preferred brand product. The DoD Pharmacy and Therapeutics Committee reviews PDE5 inhibitor placement annually based on clinical evidence and cost-effectiveness data 1.

The practical difference between tiers is cost. At a military pharmacy, generic tadalafil carries a $0 copay. Through TRICARE Home Delivery, the copay runs $16 for a 90-day supply. Retail network pharmacies charge $14 per 30-day fill for Tier 2 generics 2. Brand Cialis at retail costs $53 per fill under Tier 3.

Tadalafil received FDA approval for ED in November 2003, and the agency expanded the indication to include BPH and combined ED/BPH in 2011 3. Generic versions entered the U.S. market in September 2018 after patent expiration. TRICARE transitioned most beneficiaries to generic tadalafil at that point, and the formulary committee moved brand Cialis to non-preferred status.

For BPH-only indications, tadalafil 5 mg daily is the sole PDE5 inhibitor with FDA labeling, making it difficult for TRICARE to impose step therapy through sildenafil for this specific use 4.

Prior Authorization Requirements

TRICARE requires prior authorization for tadalafil daily-dose regimens (2.5 mg or 5 mg taken once daily). On-demand prescriptions (10 mg or 20 mg taken before sexual activity) may not require PA if the quantity stays within formulary limits of 6 tablets per 30 days 5.

The PA criteria documented in TRICARE's clinical coverage policy include: a confirmed diagnosis of ED or BPH by a credentialed provider, trial and failure (or documented contraindication) of at least one preferred PDE5 inhibitor (typically sildenafil), and absence of concurrent nitrate therapy 6. Providers must document the International Index of Erectile Function (IIEF-5) score or American Urological Association Symptom Index (AUA-SI) score in the request.

Standard PA processing takes 5-10 business days. Urgent requests (defined as situations where delay could cause serious harm) receive 72-hour processing 7. Your provider submits the PA electronically through the TRICARE contractor's portal or by fax.

A 2019 analysis of DoD pharmacy claims found that 73% of initial tadalafil PAs were approved on first submission when documentation included both an IIEF score and a statement of sildenafil inadequacy 8.

Step Therapy: What TRICARE Requires Before Approving Cialis

TRICARE's step therapy protocol for ED medications follows a fail-first model. Sildenafil (generic Viagra) is the preferred first-line PDE5 inhibitor due to its lower acquisition cost and extensive clinical trial history spanning over 25 years 9.

To satisfy step therapy, you need documentation of one of the following: an adequate trial of sildenafil (typically 4-6 attempts at appropriate doses from 25 mg to 100 mg) with inadequate response, intolerable side effects from sildenafil (headache, flushing, visual disturbance), a drug interaction that makes sildenafil inappropriate, or a clinical rationale for daily dosing that only tadalafil offers 10.

The step therapy bypass is straightforward for BPH. Because tadalafil 5 mg daily is the only PDE5 inhibitor approved for lower urinary tract symptoms secondary to BPH, TRICARE cannot require sildenafil as a step for this indication 11. If your provider codes the prescription for BPH (ICD-10 N40.1) rather than ED alone, step therapy is waived.

Brock et al. demonstrated in their 2002 randomized controlled trial (N=1,112) that tadalafil 20 mg improved erectile function in 81% of patients versus 35% on placebo, with a 36-hour duration of action that distinguishes it pharmacologically from shorter-acting alternatives 12. This extended window is a clinically valid reason to request tadalafil specifically if rigid scheduling around sildenafil's 4-6-hour window causes treatment dissatisfaction.

How to Appeal a TRICARE Denial for Cialis or Tadalafil

If TRICARE denies your tadalafil PA, you have 90 days from the denial letter date to file a formal appeal. The process routes through your TRICARE regional contractor (Humana Military for the East Region, Health Net Federal Services for the West Region) 13.

The appeal packet should include: a copy of the denial letter, a letter of medical necessity from your prescribing provider, relevant clinical documentation (IIEF scores, AUA-SI scores, prior medication trials), and any supporting literature. The Endocrine Society's 2018 clinical practice guidelines recommend PDE5 inhibitors as first-line pharmacotherapy for ED, which strengthens medical necessity arguments 14.

First-level appeals are reviewed by a clinical pharmacist at the contractor level. If denied again, second-level appeals go to the TRICARE Management Activity for independent review. Turnaround is typically 30 days per level 15.

Common denial reasons and how to address them:

Insufficient documentation of sildenafil failure. Solution: have your provider document specific dates of sildenafil use, doses attempted, and quantified outcomes (IIEF score on sildenafil versus baseline).

Quantity exceeds formulary limits. TRICARE caps on-demand tadalafil at 6 tablets per 30 days. If clinical need exceeds this, your provider must justify the higher quantity with documented sexual frequency requirements or treatment response data 16.

Diagnosis not covered. TRICARE covers tadalafil for ED and BPH only. Off-label uses (Raynaud phenomenon, pulmonary hypertension at non-standard doses) require separate clinical pathways 17.

Cost Breakdown: What You Will Pay Under TRICARE

Understanding your out-of-pocket cost depends on your TRICARE plan variant and pharmacy channel. Active-duty service members pay $0 at military pharmacies for any formulary medication. Retirees and dependents on TRICARE Prime or Select face tiered copays 18.

| Pharmacy Channel | Generic Tadalafil (Tier 2) | Brand Cialis (Tier 3) | |---|---|---| | Military Pharmacy | $0 | $0 | | Home Delivery (90-day) | $16 | $53 | | Retail Network (30-day) | $14 | $53 | | Non-network Retail | 50% cost-share | 50% cost-share |

Compare this to cash-pay prices outside insurance: brand Cialis lists at approximately $450/month, while generic tadalafil runs $8-$80/month depending on pharmacy and quantity 19. The military pharmacy channel offers the best value by a wide margin.

TRICARE For Life beneficiaries (Medicare-eligible retirees) should note that Medicare Part D does not cover ED medications under most plans. TRICARE For Life acts as secondary coverage after Medicare, but because Medicare excludes PDE5 inhibitors for ED, TRICARE For Life processes these claims as primary 20.

Using Manufacturer Savings Cards with TRICARE

Federal law prohibits the use of manufacturer copay cards, coupons, or savings programs with any federally funded insurance, including TRICARE 21. The Anti-Kickback Statute (42 U.S.C. § 1320a-7b) treats copay assistance applied to federal program prescriptions as potential inducements.

This means Lilly's Cialis savings card cannot be applied to TRICARE prescriptions at any pharmacy. Attempting to do so could result in claim reversal and potential fraud referral. However, if you are paying entirely out of pocket (not filing with TRICARE), manufacturer programs may apply since no federal claim is generated 22.

One workaround: for beneficiaries who want brand Cialis specifically and prefer to avoid the PA process, paying cash at a retail pharmacy (typically $15-$30/month for generic through GoodRx-type discount programs) may be faster than navigating prior authorization. This does not violate any federal statute because no TRICARE claim is filed 23.

Clinical Considerations for TRICARE Beneficiaries

Military populations carry specific cardiovascular and psychological comorbidity profiles that affect tadalafil prescribing. A 2019 study of active-duty and veteran populations found ED prevalence of 33% in post-deployment service members under age 40, significantly higher than the 8-12% civilian rate for the same age group 24.

Tadalafil's pharmacokinetic profile (half-life of 17.5 hours, steady-state achieved in 5 days of daily dosing) makes it particularly suitable for service members who cannot predict sexual activity timing due to operational schedules 25. The FDA-approved daily dose of 5 mg provides continuous PDE5 inhibition without requiring pre-planned dosing 26.

For service members on concurrent SSRI antidepressants (which cause ED in 25-73% of users), tadalafil daily dosing has shown benefit in SSRI-associated sexual dysfunction according to a randomized trial by Evliyaoglu et al. 27.

Providers at military treatment facilities should document the connection between service-related conditions (PTSD, TBI, SSRI use) and ED when submitting prior authorization. This strengthens the medical necessity argument and reduces denial rates 28.

Daily Dosing Versus On-Demand: Which TRICARE Covers More Easily

On-demand tadalafil (10-20 mg, taken 30 minutes to 12 hours before activity) often clears TRICARE pharmacy processing without prior authorization if quantity limits are met. Six tablets per 30-day period at 10 mg or 20 mg typically processes automatically 29.

Daily tadalafil (2.5 mg or 5 mg) always requires PA because it generates a 30-tablet-per-month fill pattern that triggers the formulary management system's utilization flag. The clinical trade-off is real: a 2007 pooled analysis of 12 randomized trials (N=2,500+) showed daily tadalafil 5 mg produced IIEF-EF domain improvements of 6.0 points versus 4.2 points for on-demand 20 mg dosing in patients with moderate-to-severe ED, likely due to continuous smooth-muscle relaxation and endothelial benefit 30.

For BPH with concurrent ED, daily 5 mg is the only evidence-based option. The landmark trial by Egerdie et al. (N=1,500) demonstrated a 4.7-point improvement in IPSS (International Prostate Symptom Score) at 12 weeks, meeting both urological and sexual function endpoints simultaneously 31.

If your provider prescribes daily dosing specifically for BPH symptoms, request they use ICD-10 code N40.1 (BPH with LUTS) as the primary diagnosis rather than N52.9 (ED). This coding distinction bypasses step therapy and often expedites PA approval because the clinical pathway is distinct from ED-only management 32.